Media headlines about Safeguard Scientifics (NYSE:SFE) have been trending somewhat positive on Wednesday, Accern Sentiment reports. Accern scores the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Safeguard Scientifics earned a news sentiment score of 0.12 on Accern’s scale. Accern also assigned news headlines about the asset manager an impact score of 46.5150201105492 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Shares of SFE stock traded down $0.18 during mid-day trading on Wednesday, hitting $12.97. 11,270 shares of the stock traded hands, compared to its average volume of 108,298. The firm has a market cap of $265.23 million, a price-to-earnings ratio of -2.99 and a beta of 1.26. Safeguard Scientifics has a 52-week low of $10.75 and a 52-week high of $14.40. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.80 and a current ratio of 0.80.
Safeguard Scientifics (NYSE:SFE) last released its quarterly earnings results on Thursday, April 26th. The asset manager reported ($0.30) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.72) by $0.42. equities analysts predict that Safeguard Scientifics will post -2.66 earnings per share for the current fiscal year.
Safeguard Scientifics Company Profile
Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings in Fintech sector. It initially invests in a Series A-C round and opportunistically in a seed round.
Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.